These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29095252)

  • 21. Association of Interleukin-28B Polymorphisms (rs12979860 C/T, rs12980275 A/G, rs8099917 T/G) and Risk of Hepatocellular Carcinoma in an Iranian Population.
    Hajizadeh L; Samaei NM; Bazgir A; Agha Gholizadeh M; Khosravi A
    Middle East J Dig Dis; 2022 Jan; 14(1):118-123. PubMed ID: 36619736
    [No Abstract]   [Full Text] [Related]  

  • 22. Extracellular Matrix Proteins Substantiate IL-28B T allele Effect on Histological Outcome of Chronic Hepatitis C.
    Attallah AM; Omran D; Omran MM; Abdelrazek MA; Zayed R; Essawey RE; Saif S; Farid A; Hassany M; Yosry A; Omar A
    Ann Hepatol; 2018 July - August ,; 17(4):569-576. PubMed ID: 29893697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of associations of interleukin-28B polymorphisms rs8099917 and rs12979860 with development of hepatitis virus-related hepatocellular carcinoma.
    Zhang Y; Zhu SL; Chen J; Li LQ
    Onco Targets Ther; 2016; 9():3249-57. PubMed ID: 27313470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
    Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
    Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation.
    Eurich D; Boas-Knoop S; Ruehl M; Schulz M; Carrillo ED; Berg T; Neuhaus R; Neuhaus P; Neumann UP; Bahra M
    Liver Transpl; 2011 Mar; 17(3):289-98. PubMed ID: 21384511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomodulatory Function of Interleukin 28B during primary infection with cytomegalovirus.
    Egli A; Levin A; Santer DM; Joyce M; O'Shea D; Thomas BS; Lisboa LF; Barakat K; Bhat R; Fischer KP; Houghton M; Tyrrell DL; Kumar D; Humar A
    J Infect Dis; 2014 Sep; 210(5):717-27. PubMed ID: 24620020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlation between interleukin-28B genetic polymorphisms and primary hepatocellular carcinoma].
    Wang Y; Zhang HH; Chen YH; Xie XW; Liao WJ; Qin LL; Sun XY; Fei R; Wang XY; Wei L; Chen HS; Mei MH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jun; 46(6):527-32. PubMed ID: 22943900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of IL-17, IL-21, and IL-23R gene polymorphisms with HBV infection in kidney transplant patients.
    Hejr S; Karimi MH; Yaghobi R; Kamali-Sarvestani E; Geramizadeh B; Roozbeh J
    Viral Immunol; 2013 Jun; 26(3):201-6. PubMed ID: 23656167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biliary strictures after liver transplantation: role of interleukin 28B genotypes in cyclosporine treated.
    Toniutto P; Bitetto D; Falleti E; Vadalà S; Cmet S; Cussigh A; Bulajic M; Zilli M; Fabris C
    Int J Surg; 2014 Oct; 12(10):1082-7. PubMed ID: 25219480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL28B polymorphisms of both recipient and donor cooperate to influence IFN treatment response in HCV recurrence after liver transplantation, but IL28B SNPs of the recipient play a major role in IFN-induced blocking of HCV replication.
    Barbera F; Russelli G; Pipitone L; Pietrosi G; Corsale S; Vizzini G; Gridelli B; Conaldi PG
    New Microbiol; 2015 Apr; 38(2):201-10. PubMed ID: 25938745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.
    Duggal P; Thio CL; Wojcik GL; Goedert JJ; Mangia A; Latanich R; Kim AY; Lauer GM; Chung RT; Peters MG; Kirk GD; Mehta SH; Cox AL; Khakoo SI; Alric L; Cramp ME; Donfield SM; Edlin BR; Tobler LH; Busch MP; Alexander G; Rosen HR; Gao X; Abdel-Hamid M; Apps R; Carrington M; Thomas DL
    Ann Intern Med; 2013 Feb; 158(4):235-45. PubMed ID: 23420232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of IL-28B polymorphisms on the natural course of HBV infection].
    Demirtürk N; Aykın N; Çevik F; Koca B; Doğan N; Köken T
    Mikrobiyol Bul; 2016 Jan; 50(1):147-51. PubMed ID: 27058339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of
    Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
    World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of interferon λ3 gene polymorphisms, rs8099917 and rs12979860, on response to hepatitis B virus vaccination and hepatitis B or C virus infections among hemodialysis patients.
    Grzegorzewska AE; Jodłowska E; Mostowska A; Jagodziński P
    Pol Arch Med Wewn; 2015; 125(12):894-902. PubMed ID: 26658164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection.
    Fischer J; Böhm S; Scholz M; Müller T; Witt H; George J; Sarrazin C; Susser S; Schott E; Suppiah V; Booth DR; Stewart GJ; van Bömmel F; Brodzinski A; Fülöp B; Migaud P; Berg T
    Hepatology; 2012 Jun; 55(6):1700-10. PubMed ID: 22234924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of interleukin-28B genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis C.
    Hodo Y; Honda M; Tanaka A; Nomura Y; Arai K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Sakai A; Sasaki M; Nakanuma Y; Moriyama M; Kaneko S
    Clin Cancer Res; 2013 Apr; 19(7):1827-37. PubMed ID: 23426277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early reduced liver graft survival in hepatitis C recipients identified by two combined genetic markers.
    Romagnoli R; Martini S; Tandoi F; Dell Olio D; Magistroni P; Bertinetto FE; Dametto E; Rizzetto M; Salizzoni M; Amoroso A
    Transpl Int; 2016 Oct; 29(10):1070-84. PubMed ID: 27172242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patients.
    Riva E; Scagnolari C; Monteleone K; Selvaggi C; Picardi A; Mazzarelli C; Pizzigallo E; Vincenzi B; Carducci A; Antonaci S; Giannelli G; Antonelli G
    J Viral Hepat; 2012 Sep; 19(9):650-3. PubMed ID: 22863269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation.
    Kawaoka T; Takahashi S; Takaki S; Hiramatsu A; Waki K; Hiraga N; Miki D; Tsuge M; Imamura M; Kawakami Y; Aikata H; Ochi H; Onoe T; Tashiro H; Ohdan H; Chayama K
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1467-72. PubMed ID: 22432893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms in interleukin-10 and interleukin-28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin-therapy.
    Shaker OG; Sadik NA
    J Gastroenterol Hepatol; 2012 Dec; 27(12):1842-9. PubMed ID: 23020144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.